Report ID :10151870 |
Published Date : 21 Oct 2022 |
Report Format : |
Delivery Timeline :48-72 Business Hours
"In 2021, the global peptide synthesis market estimated to record a revenue of USD 400 million and is expected to expand at a compound annual growth rate of 12% during the forecast period 2022-2030. Peptide molecules have gained great traction in the health and nutrition industries. And some technological advances have been made to accomplish the required peptide production/synthesis. This trend has been observed in the synthesis of enzymatic and chemical peptides. Chemical synthesis is considered to be the conventional and most widely used technique for peptide production, but the lack of specificity and the risk of increased environmental load will hinder growth. Chemical synthesis of peptides. This has driven the adoption of enzyme technology for peptide synthesis.
Product information:
The global peptide synthesis market is divided into three parts according to product names, equipment, reagents and consumables. Peptide synthesis kits are further discussed in four subsections, including protein synthesizers, freeze dryers, chromatography kits, etc. Extensive research aimed at manufacturing new peptide synthesis equipment has contributed to the fastest growth of this segment in the global market. For example, in February 2017, MIT researchers launched new kits that can synthesize peptides faster than existing kits. in the market. Researchers at the Massachusetts Institute of Technology have created an automated machine that can form connections between amino acids in about 37 seconds; this helps to produce large quantities of customized peptides in a shorter time. Among other peptide synthesis products, reagents and consumables have the highest revenue; this is due to its routine use in peptide synthesis schemes. In addition, the latest development of peptide coupling reagents is expected to drive market growth in the next few years.
Technical know-how:
According to technology, the market is divided into three parts, namely solid phase peptide synthesis (SPPS), liquid phase peptide synthesis (LPPS) and hybrid technology. Liquid-phase peptide synthesis has dominated the global market throughout the forecast period, while solid-phase peptide synthesis will grow the fastest from 2022 to 2030. Reduce costs associated with peptide synthesis. This is expected to increase the global adoption of peptide synthesis, which will contribute to the global revenue generated during the forecast period. Traditional studies have shown that SPPS can be used as a suitable method for GMP manufacturing and API process development, because SPPS is cost-effective to synthesize long peptide sequences (more than 10 amino acids) in a small volume.
However, during SPPS, the costs associated with purification tend to push up manufacturing costs for any desired production scale. Liquid-phase peptide synthesis is most commonly used to develop shorter peptide sequences and larger volumes; hybrid methods are used to synthesize a large number of long sequences.
Application information:
According to the application, the peptide synthesis market can be subdivided into treatment, diagnosis, and research. The income of the treatment department includes cancer, metabolism, cardiovascular, respiratory, gastrointestinal diseases, infectious diseases, pain, skin diseases, central nervous system, kidneys, etc.
The therapeutic field dominated the peptide synthesis application market in 2020 and is expected to maintain this trend throughout the forecast period. Whereas, the diagnostic part will grow at the fastest rate between 2022-2030. Synthetic peptides are widely used in cancer treatment, which makes this part a major contributor to the income generated by the treatment part.
The metabolic disorder segment will grow at the fastest rate during the forecast period. This growth is attributed to the presence of a strong product portfolio and a large number of candidate peptides for the treatment of type II diabetes. The newly discovered peptides that play a key role in metabolic regulation are expected to provide useful information for the design of effective treatments.
Regional perspectives:
Geographical regions such as North America, Asia Pacific, Asia Pacific, Latin America, and MEA have witnessed the complementary demand for peptide synthesis technology in diagnostic, research, and therapeutic applications. Among the aforementioned regions, North America contributes the most to the global market due to the strong presence of major market players, increased awareness of available peptide synthesis technologies, and increasing attention to the promotion of peptide drugs to commercial scale.
However, due to increased investment by market participants in the region, increasing awareness of new peptide treatments, increased healthcare expenditures by some governments and patients, and cooperation with multinational companies, the Asia-Pacific region is expected to perform the fastest during the forecast period. increase. Distribution with local participants and the increasing incidence of chronic diseases in low- and middle-income countries.
Peptide synthesis market outlook:
Over the years, the market has experienced a lot of consolidation. For example, in January 2018, Imcyse SA announced a research collaboration with Pfizer to develop Isotope, a specially modified peptide. The peptide is synthesized to treat rheumatoid arthritis. The manufacturer of Imcyse SA is actively focusing on immunotherapy for the treatment of chronic diseases. Some of the major players in the market include Genscript Biotech, Merck KGaA, Bachem Holdings, Biotage, CEM Corporation, Thermo Fisher, Creative Diagnostics, Polypeptide Group, Syngene, PuroSynth, Lonza, MP Biomedicals and Novo Nordisk A/S.
MARKET SEGMENTS COVERED BY THE REPORT:
The report forecasts global, regional, and national revenue growth, and analyzes the latest industry trends in each sub-segment from 2022-2030. In this research, Kenneth Research has subdivided the global peptide synthesis market report based on product, technology, application, end use and region: Product Outlook (Revenue, USD million, 2022-2030) Equipment Peptide Synthesizer Liofilizers Chromatography equipment, other reagents and consumables, and other technology outlook (revenue, million dollars, 2022-2030) in-phase peptide synthesis (SPPS) liquid phase peptide synthesis (LPPS) hybrid technology application outlook (revenue, million dollars, 2022-2030) ) Therapeutics Cancer Metabolic Cardiovascular Disorder RespiratoryGIT (gastrointestinal disease) Infectious disease PainDermatology CNSRenal Otresionistas tico 26. The company develops and manufactures contract ring organization/contract research organization academic and research institutions. "
<
Why Choose Kenneth Research ?
-
Insight with Impact : We don’t just gather data — we uncover stories, trends, and opportunities that fuel business growth.
-
Experts Who Get It : Our team speaks your industry’s language and knows what really matters to your customers and market.
-
Custom-Built for You : Forget one-size-fits-all. We craft research and consulting solutions as unique as your business vision.
-
Partners, Not Just Providers : We work with you, not for you — collaborating closely to turn insights into smart, strategic moves.
-
Results That Speak : Our work powers brands, startups, and industry leaders alike — with a track record of ideas that work in the real world.
